Lowenthal Richard E 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-11-18 2:09 pm Purchase | 2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY | Lowenthal Richard E | 7,422,432 7.900% | 7,422,432 (New Position) | Filing |